Systemic administration of c-Kit+ cells diminished pulmonary and vascular inflammation in rat model of chronic asthma

[1] Afzal S(2020)Alternative approaches for the treatment of Asthma and COPD: Focus on Cell-based therapies, Epigenetics, and Gene silencing approaches Advancements in Life Sciences 7 181-189

[2] Ramzan K(2019)Bone marrow mesenchymal stem cells and condition media diminish inflammatory adhesion molecules of pulmonary endothelial cells in an ovalbumin-induced asthmatic rat model Microvasc Res 121 63-70

[3] Waqar AB(2008)Mouse models of allergic asthma: acute and chronic allergen challenge Dis Model Mech 1 213-220

[4] Rahbarghazi R(2018)Monitoring IL-13 expression in relation to miRNA-155 and miRNA-133 changes following intra-tracheal administration of mesenchymal stem cells and conditioned media in ovalbumin-sensitized rats The Thai Journal of Veterinary Medicine 48 347-355

[5] Keyhanmanesh R(2004)Prolonged allergen challenge in mice leads to persistent airway remodelling Clin Exp Allergy 34 497-507

[6] Aslani MR(2002)Modeling allergic asthma in mice: pitfalls and opportunities Am J Respir Cell Mol Biol 27 267-272

[7] Hassanpour M(2020)The potential of mesenchymal stem cell therapy for chronic lung disease Expert Rev Respir Med 14 31-39

[8] Ahmadi M(2020)Unraveling the therapeutic effects of mesenchymal stem cells in asthma Stem Cell Res Ther 11 1-12

[9] Nials AT(2021)c-kit+ cells offer hopes in ameliorating asthmatic pathologies via regulation of miRNA-133 and-126 Iran J Basic Med Sci 24 369-376

[10] Uddin S(2014)Stem cells in animal asthma models: a systematic review Cytotherapy 16 1629-1642

[1] Afzal S(2020)Alternative approaches for the treatment of Asthma and COPD: Focus on Cell-based therapies, Epigenetics, and Gene silencing approaches Advancements in Life Sciences 7 181-189

[2] Ramzan K(2019)Bone marrow mesenchymal stem cells and condition media diminish inflammatory adhesion molecules of pulmonary endothelial cells in an ovalbumin-induced asthmatic rat model Microvasc Res 121 63-70

[3] Waqar AB(2008)Mouse models of allergic asthma: acute and chronic allergen challenge Dis Model Mech 1 213-220

[4] Rahbarghazi R(2018)Monitoring IL-13 expression in relation to miRNA-155 and miRNA-133 changes following intra-tracheal administration of mesenchymal stem cells and conditioned media in ovalbumin-sensitized rats The Thai Journal of Veterinary Medicine 48 347-355

[5] Keyhanmanesh R(2004)Prolonged allergen challenge in mice leads to persistent airway remodelling Clin Exp Allergy 34 497-507

[6] Aslani MR(2002)Modeling allergic asthma in mice: pitfalls and opportunities Am J Respir Cell Mol Biol 27 267-272

[7] Hassanpour M(2020)The potential of mesenchymal stem cell therapy for chronic lung disease Expert Rev Respir Med 14 31-39

[8] Ahmadi M(2020)Unraveling the therapeutic effects of mesenchymal stem cells in asthma Stem Cell Res Ther 11 1-12

[9] Nials AT(2021)c-kit+ cells offer hopes in ameliorating asthmatic pathologies via regulation of miRNA-133 and-126 Iran J Basic Med Sci 24 369-376

[10] Uddin S(2014)Stem cells in animal asthma models: a systematic review Cytotherapy 16 1629-1642